Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Total
Previously Reported [Member]
Revision of Prior Period, Adjustment
Series A Convertible Preferred Stock [Member]
Previously Reported [Member]
Series A Convertible Preferred Stock [Member]
Revision of Prior Period, Adjustment
Series B Convertible Preferred Stock [Member]
Previously Reported [Member]
Series B Convertible Preferred Stock [Member]
Revision of Prior Period, Adjustment
Common Stock [Member]
Common Stock [Member]
Previously Reported [Member]
Old Gemini [Member]
Common Stock [Member]
Revision of Prior Period, Adjustment
Common Stock [Member]
Revision of Prior Period, Adjustment
Old Gemini [Member]
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported [Member]
Additional Paid-in Capital
Revision of Prior Period, Adjustment
Retained Earnings
Retained Earnings
Previously Reported [Member]
Balance at Dec. 31, 2019 $ (10,432,000) $ (70,797,000) $ 60,365,000         $ 1,000 $ 5,000 $ 1,000 $ (5,000) $ 61,551,000 $ 1,182,000 $ 60,369,000 $ (71,984,000) $ (71,984,000)
Balance, shares at Dec. 31, 2019       39,722,088 (39,722,088) 9,916,375 (9,916,375)                  
Balance at Dec. 31, 2019       $ 47,113,000 $ (47,113,000) $ 13,252,000 $ (13,252,000)                  
Balance (in Shares) at Dec. 31, 2019               11,979,586 5,313,766 11,979,586 (5,313,766)          
Issuance of Series B convertible preferred stock, net of issuance costs of $16               3,242,655                
Issuance of Series B convertible preferred stock, net of issuance costs of $16 20,084,000             $ 1,000       20,083,000        
Beneficial conversion feature relating to discount on convertible promissory notes 8,177,000                     8,177,000        
Issuance of common stock upon exercise of stock options 164,000                     164,000        
Exercised               285,260                
Vesting of restricted common stock (in Shares)               57,879                
Stock-based compensation expense 983,000                     983,000        
Net loss (40,837,000)                           (40,837,000)  
Balance at Dec. 31, 2020 (21,861,000) $ 102,310,000 $ 80,449,000         $ 2,000 $ 7,000 $ 2,000 $ (7,000) 90,958,000 $ 10,504,000 $ 80,454,000 (112,821,000) $ (112,821,000)
Balance at Dec. 31, 2020       39,722,088 (39,722,088) 24,790,938 (24,790,938)                  
Balance at Dec. 31, 2020       $ 47,113,000 $ (47,113,000) $ 33,336,000 $ (33,336,000)                  
Balance (in Shares) at Dec. 31, 2020               15,565,380 6,900,493 15,565,380 (6,900,493)          
Issuance of common stock upon Business Combination, net of issuance costs (Note 2) 195,882,000             $ 2,000       195,880,000        
Conversion of promissory notes (Note 2) 14,515,000                     14,515,000        
Conversion of promissory notes (in Shares)               2,341,316                
Issuance of common stock upon exercise of warrants (Note 2) 76,000             $ 15,257       76,000        
Issuance of common stock upon Business Combination, net of issuance costs (in Shares)               25,041,150                
Issuance of common stock upon exercise of stock options $ 311,000                     311,000        
Exercised 208,890             209,495                
Vesting of restricted common stock (in Shares)               35,561                
Stock-based compensation expense $ 7,787,000                     7,787,000        
Net loss (71,869,000)                           (71,869,000)  
Balance at Dec. 31, 2021 $ 124,841,000             $ 4,000       $ 309,527,000     $ (184,690,000)  
Balance (in Shares) at Dec. 31, 2021               43,208,159